The DOI matches its Crossref record; 255 of the 255 references it cites were found in a registry or an index.
Metabolic functions of the tumor suppressor p53: Implications in normal physiology, metabolic disorders, and cancer
Open accessAbstract
BACKGROUND: The TP53 gene is one of the most commonly inactivated tumor suppressors in human cancers. p53 functions during cancer progression have been linked to a variety of transcriptional and non-transcriptional activities that lead to the tight control of cell proliferation, senescence, DNA repair, and cell death. However, converging evidence indicates that p53 also plays a major role in metabolism in both normal and cancer cells. SCOPE OF REVIEW: We provide an overview of the current knowledge on the metabolic activities of wild type (WT) p53 and highlight some of the mechanisms by which p53 contributes to whole body energy homeostasis. We will also pinpoint some evidences suggesting that deregulation of p53-associated metabolic activities leads to human pathologies beyond cancer, including obesity, diabetes, liver, and cardiovascular diseases. MAJOR CONCLUSIONS: p53 is activated when cells are metabolically challenged but the origin, duration, and intensity of these stresses will dictate the outcome of the p53 response. p53 plays pivotal roles both upstream and downstream of several key metabolic regulators and is involved in multiple feedback-loops that ensure proper cellular homeostasis. The physiological roles of p53 in metabolism involve complex mechanisms of regulation implicating both cell autonomous effects as well as autocrine loops. However, the mechanisms by which p53 coordinates metabolism at the organismal level remain poorly understood. Perturbations of p53-regulated metabolic activities contribute to various metabolic disorders and are pivotal during cancer progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p53 regulates a series of metabolic diseases, including obesity, diabetes, and fatty liver diseases, through its complicated functions.125,261,262”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [261]
In the citing paper
“Although no clear clinical evidence is available that disordered p53 directly promotes type I diabetes, dysfunctional p53 can induce critical biological processes in diabetes, including disturbances in glucose homeostasis at the organismal level, pancreatic β-cell deficiency, and insulin resistance in peripheral tissues.261”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [261]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Ide, T., Brown‐Endres, L., Chu, K., Ongusaha, P. P., Ohtsuka, T., El‐Deiry, W. S., Aaronson, S. A., & Lee, S. W. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.031 · Cited by 105
RetractedRETRACTED ARTICLE:Exercise-induced mitochondrial p53 repairs mtDNA mutations in mutator mice
Safdar, A., Khrapko, K., Flynn, J. M., Saleem, A., Lisio, M. D., Johnston, A. P. W., Kratysberg, Y., Samjoo, I. A., Kitaoka, Y., Ogborn, D. I., et al. (2015) · Skeletal Muscle · doi:10.1186/s13395-016-0075-9 · Cited by 68
RetractedOxyl radicals, redox-sensitive signalling cascades and antioxidants
Genestra, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.009 · Cited by 4,930
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
A model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019 · cited 14×
“On the other hand, cytoplasmic p53 inhibits directly the activity of G6P-dehydrogenase (G6PD), the enzyme that controls the first and rate limiting step of the PPP, by preventing the formation of the active dimer [42].”
BackgroundInfluentialRegulation of cellular metabolism by protein lysine acetylation
Zhao, S., Xu, W., Jiang, W., Yu, W., Lin, Y., Zhang, T., Yao, J., Zhou, L., Zeng, Y., Li, H., et al. (2010) · Science · doi:10.1126/science.1179689 · Cited by 1,910
p53 Regulates Mitochondrial Respiration
Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650
Iron and cancer: more ore to be mined
Torti, S. V., & Torti, F. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3495 · Cited by 1,621 · cited 1×
“p53, iron metabolism and ferroptosis Iron plays a critical role in a variety of biological processes including cell proliferation, and cancer cells display a stronger dependence on iron than do normal cells [64].”
BackgroundAMP-activated protein kinase induces a p53-dependent metabolic checkpoint
Jones, R. G., Plas, D. R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., Birnbaum, M. J., & Thompson, C. B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.027 · Cited by 1,619
Substrate and Functional Diversity of Lysine Acetylation Revealed by a Proteomics Survey
Kim, S. C., Sprung, R., Chen, Y., Xu, Y., Ball, H., Pei, J., Cheng, T., Kho, Y., Xiao, H., Xiao, L., et al. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.026 · Cited by 1,487
DRAM, a p53-Induced Modulator of Autophagy, Is Critical for Apoptosis
Crighton, D., Wilkinson, S., O'Prey, J., Syed, N., Smith, P., Harrison, P. R., Gasco, M., Garrone, O., Crook, T., & Ryan, K. M. (2006) · Cell · doi:10.1016/j.cell.2006.05.034 · Cited by 1,380
miR-34a repression of SIRT1 regulates apoptosis
Yamakuchi, M., Ferlito, M., & Lowenstein, C. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801613105 · Cited by 1,342
p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling
Budanov, A. V., & Karin, M. (2008) · Cell · doi:10.1016/j.cell.2008.06.028 · Cited by 1,326
Telomere dysfunction induces metabolic and mitochondrial compromise
Sahin, E., Colla, S., Liesa, M., Moslehi, J., Müller, F. L., Guo, M., Cooper, M., Kotton, D., Fabian, A. J., Walkey, C., et al. (2011) · Nature · doi:10.1038/nature09787 · Cited by 1,319
The coordinate regulation of the p53 and mTOR pathways in cells
Feng, Z., Zhang, H., Levine, A. J., & Jin, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502857102 · Cited by 1,235
A Global Map of p53 Transcription-Factor Binding Sites in the Human Genome
Wei, C.-L., Wu, Q., Vega, V. B., Chiu, K. P., Ng, P., Zhang, T., Shahab, A., Yong, H. C., Fu, Y., Weng, Z., et al. (2006) · Cell · doi:10.1016/j.cell.2005.10.043 · Cited by 1,141
Regulation of autophagy by cytoplasmic p53
Tasdemir, E., Maiuri, M. C., Galluzzi, L., Vitale, I., Djavaheri-Mergny, M., D'Amelio, M., Criollo, A., Morselli, E., Zhu, C., Harper, F., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1730 · Cited by 1,132
The antioxidant function of the p53 tumor suppressor
Sablina, A. A., Budanov, A. V., Ilyinskaya, G. V., Agapova, L. S., Kravchenko, J. E., & Chumakov, P. M. (2005) · Nature Medicine · doi:10.1038/nm1320 · Cited by 1,121
Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice
Cheng, H.-L., Mostoslavsky, R., Saito, S., Manis, J. P., Gu, Y., Patel, P., Bronson, R., Appella, E., Alt, F. W., & Chua, K. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934713100 · Cited by 1,095
P53 in survival, death and metabolic health: a lifeguard with a licence to kill.
Kruiswijk, F., Labuschagne, C. F., & Vousden, K. H. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4007 · Cited by 1,080
Acetylation of Metabolic Enzymes Coordinates Carbon Source Utilization and Metabolic Flux
Wang, Q., Zhang, Y., Yang, C., Xiong, H., Lin, Y., Yao, J., Li, H., Xie, L., Zhao, W., Yao, Y., et al. (2010) · Science · doi:10.1126/science.1179687 · Cited by 1,008
Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells
Maddocks, O. D. K., Berkers, C. R., Mason, S. M., Zheng, L., Blyth, K., Gottlieb, E., & Vousden, K. H. (2013) · Nature · doi:10.1038/nature11743 · Cited by 1,007
The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity
Xie, Y., Zhu, S., Song, X., Sun, X., Fan, Y., Liu, J., Zhong, M., Yuan, H., Zhang, L., Billiar, T. R., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.055 · Cited by 952
HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation
Zhou, B. P., Liao, Y., Xia, W., Zou, Y., Spohn, B., & Hung, M.-C. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-973 · Cited by 951 · cited 1×
“The links between AKT and the p53 pathway are also illustrated by AKT-mediated phosphorylation of MDM2, the key negative regulator of p53 [161,162].”
BackgroundRegulation of PTEN Transcription by p53
Stambolic, V., MacPherson, D., Sas, D., Lin, Y., Snow, B., Jang, Y., Benchimol, S., & Mak, T. W. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00323-9 · Cited by 912
Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence
Li, T., Kon, N., Jiang, L., Tan, M., Ludwig, T., Zhao, Y., Baer, R., & Gu, W. (2012) · Cell · doi:10.1016/j.cell.2012.04.026 · Cited by 912
A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage
Tanaka, H., Arakawa, H., Yamaguchi, T., Shiraishi, K., Fukuda, S., Matsui, K., Takei, Y., & Nakamura, Y. (2000) · Nature · doi:10.1038/35003506 · Cited by 904
Death Signal-induced Localization of p53 Protein to Mitochondria
Marchenko, N. D., Zaika, A., & Moll, U. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.16202 · Cited by 901
A crucial role for adipose tissue p53 in the regulation of insulin resistance
Minamino, T., Orimo, M., Shimizu, I., Kunieda, T., Yokoyama, M., Ito, T., Nojima, A., Nabetani, A., Oike, Y., Matsubara, H., et al. (2009) · Nature Medicine · doi:10.1038/nm.2014 · Cited by 891
ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway
Chu, B., Kon, N., Chen, D., Li, T., Liu, T., Jiang, L., Song, S., Tavana, O., & Gu, W. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0305-6 · Cited by 882
Induction of the growth inhibitor IGF-binding protein 3 by p53
Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. R., & Kley, N. (1995) · Nature · doi:10.1038/377646a0 · Cited by 869
Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function
Hu, W., Zhang, C., Wu, R., Sun, Y., Levine, A., & Feng, Z. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001006107 · Cited by 862
Stabilization of wild-type p53 by hypoxia-inducible factor 1α
An, W. G., Kanekal, M., Simon, M. C., Maltepe, E., Blagosklonny, M. V., & Neckers, L. M. (1998) · Nature · doi:10.1038/32925 · Cited by 827
p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase
Jiang, P., Du, W., Wang, X., Mancuso, A., Gao, X., Wu, M., & Yang, X. (2011) · Nature Cell Biology · doi:10.1038/ncb2172 · Cited by 795
Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases
Hallows, W. C., Lee, S., & Denu, J. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604392103 · Cited by 792
Mitochondrial p53 activates Bak and causes disruption of a Bak–Mcl1 complex
Leu, J. I.-J., Dumont, P., Hafey, M., Murphy, M. E., & George, D. L. (2004) · Nature Cell Biology · doi:10.1038/ncb1123 · Cited by 770
Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses
Ou, Y., Wang, S.-J., Li, D., Chu, B., & Gu, W. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607152113 · Cited by 765
p53 Opens the Mitochondrial Permeability Transition Pore to Trigger Necrosis
Vaseva, A. V., Marchenko, N. D., Ji, K., Tsirka, S. E., Holzmann, S., & Moll, U. M. (2012) · Cell · doi:10.1016/j.cell.2012.05.014 · Cited by 740
The Tumor Suppressor p53 Down-Regulates Glucose Transporters GLUT1 and GLUT4 Gene Expression
Schwartzenberg-Bar-Yoseph, F., Armoni, M., & Karnieli, E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0846 · Cited by 726
p53 status determines the role of autophagy in pancreatic tumour development
Rosenfeldt, M. T., O’Prey, J., Morton, J. P., Nixon, C., MacKay, G., Mrowinska, A., Au, A., Rai, T. S., Zheng, L., Ridgway, R., et al. (2013) · Nature · doi:10.1038/nature12865 · Cited by 713
Barlev, N. A., Liu, L., Chehab, N. H., Mansfield, K., Harris, K. G., Halazonetis, T. D., & Berger, S. L. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00414-2 · Cited by 710
Suzuki, S., Tanaka, T., Poyurovsky, M. V., Nagano, H., Mayama, T., Ohkubo, S., Lokshin, M., Hosokawa, H., Nakayama, T., Suzuki, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002459107 · Cited by 705
Nutrient Availability Regulates SIRT1 Through a Forkhead-Dependent Pathway
Nemoto, S., Fergusson, M. M., & Finkel, T. (2004) · Science · doi:10.1126/science.1101731 · Cited by 677
Glycolytic Enzymes Can Modulate Cellular Life Span
Kondoh, H., Lleonart, M. E., Gil, J., Wang, J., Degan, P., Peters, G., Martinez, D., Carnero, A., & Beach, D. (2005) · Cancer Research · doi:10.1158/0008-5472.177.65.1 · Cited by 647 · cited 2×
“This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). www.molecularmetabolism.com the downregulation of the glycolytic enzyme phosphoglycerate mutase (PGM) [16,17].”
BackgroundInfluentialp53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation
Kawauchi, K., Araki, K., Tobiume, K., & Tanaka, N. (2008) · Nature Cell Biology · doi:10.1038/ncb1724 · Cited by 637
Feng, Z., Hu, W., de Stanchina, E., Teresky, A. K., Jin, S., Lowe, S., & Levine, A. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4149 · Cited by 633
Guo, J. Y., Karsli-Uzunbas, G., Mathew, R., Aisner, S. C., Kamphorst, J. J., Strohecker, A. M., Chen, G., Price, S., Lu, W., Teng, X., et al. (2013) · Genes & Development · doi:10.1101/gad.219642.113 · Cited by 589
miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1
Wang, J.-X., Jiao, J.-Q., Li, Q., Long, B., Wang, K., Liu, J.-P., Li, Y.-R., & Li, P.-F. (2011) · Nature Medicine · doi:10.1038/nm.2282 · Cited by 582
MDM2–HDAC1-mediated deacetylation of p53 is required for its degradation
Ito, A., Kawaguchi, Y., Lai, C., Kovacs, J. J., Higashimoto, Y., Appella, E., & Yao, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf616 · Cited by 570
p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells
Tarangelo, A., Magtanong, L., Bieging-Rolett, K. T., Li, Y., Ye, J., Attardi, L. D., & Dixon, S. J. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.077 · Cited by 554
Hypoxia-Modified Cancer Cell Metabolism
Al Tameemi, W., Dale, T. P., Al-Jumaily, R. M. K., & Forsyth, N. R. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00004 · Cited by 503
Bae, S. H., Sung, S. H., Oh, S. Y., Lim, J. M., Lee, S. K., Park, Y. N., Lee, H. E., Kang, D., & Rhee, S. G. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.002 · Cited by 492
Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence
Jiang, P., Du, W., Mancuso, A., Wellen, K. E., & Yang, X. (2013) · Nature · doi:10.1038/nature11776 · Cited by 491
Ellisen, L. W., Ramsayer, K. D., Johannessen, C. M., Yang, A., Beppu, H., Minda, K., Oliner, J. D., McKeon, F., & Haber, D. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00706-2 · Cited by 474
Forrester, K., Ambs, S., Lupold, S. E., Kapust, R. B., Spillare, E. A., Weinberg, W. C., Felley-Bosco, E., Wang, X. W., Geller, D. A., Tzeng, E., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2442 · Cited by 469
Delayed ageing through damage protection by the Arf/p53 pathway
Matheu, A., Maraver, A., Klatt, P., Flores, I., Garcia-Cao, I., Borras, C., Flores, J. M., Viña, J., Blasco, M. A., & Serrano, M. (2007) · Nature · doi:10.1038/nature05949 · Cited by 466
Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor Suppression
Wang, S.-J., Li, D., Ou, Y., Jiang, L., Chen, Y., Zhao, Y., & Gu, W. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.022 · Cited by 462
Kenzelmann Broz, D., Spano Mello, S., Bieging, K. T., Jiang, D., Dusek, R. L., Brady, C. A., Sidow, A., & Attardi, L. D. (2013) · Genes & Development · doi:10.1101/gad.212282.112 · Cited by 443 · cited 2×
“HAMP Hepcidin activated reporter assays, EMSA, ChIP [65] FXN Frataxin activated reporter assays, EMSA, ChIP [69] Ferroptosis SLC7A11 Solute carrier family 7 member 11 repressed ChIP-qPCR, EMSA [79,84] SAT1 Spermidine/spermine N1-acetyltransferase 1 activated ChIP-qPCR [83] Redox SESN1 Sestrin 1 activated reporter assa…”
Trinei, M., Giorgio, M., Cicalese, A., Barozzi, S., Ventura, A., Migliaccio, E., Milia, E., Padura, I. M., Raker, V. A., Maccarana, M., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205513 · Cited by 436
p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression
Moon, S.-H., Huang, C.-H., Houlihan, S. L., Regunath, K., Freed-Pastor, W. A., Morris, J. P., Tschaharganeh, D. F., Kastenhuber, E. R., Barsotti, A. M., Culp-Hill, R., et al. (2019) · Cell · doi:10.1016/j.cell.2018.11.011 · Cited by 435
Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect
Zhang, C., Lin, M., Wu, R., Wang, X., Yang, B., Levine, A. J., Hu, W., & Feng, Z. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113884108 · Cited by 431
Hwang, P. M., Bunz, F., Yu, J., Rago, C., Chan, T. A., Murphy, M. P., Kelso, G. F., Smith, R. A. J., Kinzler, K. W., & Vogelstein, B. (2001) · Nature Medicine · doi:10.1038/nm1001-1111 · Cited by 422
Mitochondrial Dysfunction Contributes to Oncogene-Induced Senescence
Moiseeva, O., Bourdeau, V., Roux, A., Deschênes-Simard, X., & Ferbeyre, G. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01868-08 · Cited by 408
p53-Induced Up-Regulation of MnSOD and GPx but not Catalase Increases Oxidative Stress and Apoptosis
Hussain, S. P., Amstad, P., He, P., Robles, A., Lupold, S., Kaneko, I., Ichimiya, M., Sengupta, S., Mechanic, L., Okamura, S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-2287-2 · Cited by 384
Guo, X., Disatnik, M.-H., Monbureau, M., Shamloo, M., Mochly-Rosen, D., & Qi, X. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70911 · Cited by 370
Han, M.-K., Song, E.-K., Guo, Y., Ou, X., Mantel, C., & Broxmeyer, H. E. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.01.002 · Cited by 368
Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability
Budanov, A. V., Shoshani, T., Faerman, A., Zelin, E., Kamer, I., Kalinski, H., Gorodin, S., Fishman, A., Chajut, A., Einat, P., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205877 · Cited by 362
Li, J., Donath, S., Li, Y., Qin, D., Prabhakar, B. S., & Li, P. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000795 · Cited by 361
Atg7 Modulates p53 Activity to Regulate Cell Cycle and Survival During Metabolic Stress
Lee, I. H., Kawai, Y., Fergusson, M. M., Rovira, I. I., Bishop, A. J. R., Motoyama, N., Cao, L., & Finkel, T. (2012) · Science · doi:10.1126/science.1218395 · Cited by 355
Jennis, M., Kung, C.-P., Basu, S., Budina-Kolomets, A., Leu, J. I.-J., Khaku, S., Scott, J. P., Cai, K. Q., Campbell, M. R., Porter, D. K., et al. (2016) · Genes & Development · doi:10.1101/gad.275891.115 · Cited by 352
p53DINP1, a p53-Inducible Gene, Regulates p53-Dependent Apoptosis
Okamura, S., Arakawa, H., Tanaka, T., Nakanishi, H., Ng, C. C., Taya, Y., Monden, M., & Nakamura, Y. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00284-2 · Cited by 351
Koumenis, C., Alarcon, R., Hammond, E., Sutphin, P., Hoffman, W., Murphy, M., Derr, J., Taya, Y., Lowe, S. W., Kastan, M., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1297-1310.2001 · Cited by 346
Imamura, K., Ogura, T., Kishimoto, A., Kaminishi, M., & Esumi, H. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5627 · Cited by 344
Direct Interactions between HIF-1α and Mdm2 Modulate p53 Function
Chen, D., Li, M., Luo, J., & Gu, W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200694200 · Cited by 334
Donald, S. P., Sun, X. Y., Hu, C.-A. A., Yu, J., Mei, J. M., Valle, D. L., & Phang, J. M. (2001) · PubMed · Cited by 325
Hypoxia Links ATR and p53 through Replication Arrest
Hammond, E. M., Denko, N. C., Dorie, M. J., Abraham, R. T., & Giaccia, A. J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.6.1834-1843.2002 · Cited by 324
PML Is a Direct p53 Target that Modulates p53 Effector Functions
de Stanchina, E., Querido, E., Narita, M., Davuluri, R. V., Pandolfi, P. P., Ferbeyre, G., & Lowe, S. W. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00062-0 · Cited by 312
Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming
Ong, A. L. C., & Ramasamy, T. S. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.02.004 · Cited by 301
Tumor suppressor p53 and metabolism
Liu, J., Zhang, C., Hu, W., & Feng, Z. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy070 · Cited by 300
Proline Metabolism in Cell Regulation and Cancer Biology: Recent Advances and Hypotheses
Phang, J. M. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7350 · Cited by 296
α-Ketoglutarate links p53 to cell fate during tumour suppression
Morris, J. P., Yashinskie, J. J., Koche, R., Chandwani, R., Tian, S., Chen, C.-C., Baslan, T., Marinkovic, Z. S., Sánchez-Rivera, F. J., Leach, S. D., et al. (2019) · Nature · doi:10.1038/s41586-019-1577-5 · Cited by 296
Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol γ
Achanta, G., Sasaki, R., Feng, L., Carew, J. S., Lu, W., Pelicano, H., Keating, M. J., & Huang, P. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600819 · Cited by 285
Okoshi, R., Ozaki, T., Yamamoto, H., Ando, K., Koida, N., Ono, S., Koda, T., Kamijo, T., Nakagawara, A., & Kizaki, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705232200 · Cited by 277
Reciprocal influence of the p53 and the hypoxic pathways
Sermeus, A., & Michiels, C. (2011) · Cell Death & Disease · doi:10.1038/cddis.2011.48 · Cited by 265
Transcriptional Activation of the Human Glutathione Peroxidase Promoter by p53
Tan, M., Li, S., Swaroop, M., Guan, K., Oberley, L. W., & Sun, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.12061 · Cited by 253
Velasco-Miguel, S., Buckbinder, L., Jean, P., Gelbert, L., Talbott, R., Laidlaw, J., Seizinger, B., & Kley, N. (1999) · Oncogene · doi:10.1038/sj.onc.1202274 · Cited by 252
Zhao, Y., Chaiswing, L., Velez, J. M., Batinic-Haberle, I., Colburn, N. H., Oberley, T. D., & St. Clair, D. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3835 · Cited by 245 · cited 3×
“Paradoxically, p53 has also been reported to repress SOD2 promoter by binding to its transcriptional activator SP1 [125].”
Backgroundp53 Negatively Regulates Transcription of the Pyruvate Dehydrogenase Kinase Pdk2
Contractor, T., & Harris, C. R. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1215 · Cited by 245
A systematic review of p53 regulation of oxidative stress in skeletal muscle
Beyfuss, K., & Hood, D. A. (2018) · Redox Report · doi:10.1080/13510002.2017.1416773 · Cited by 239
PH Domain-Only Protein PHLDA3 Is a p53-Regulated Repressor of Akt
Kawase, T., Ohki, R., Shibata, T., Tsutsumi, S., Kamimura, N., Inazawa, J., Ohta, T., Ichikawa, H., Aburatani, H., Tashiro, F., et al. (2009) · Cell · doi:10.1016/j.cell.2008.12.002 · Cited by 237
Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses
Yoon, K.-A., Nakamura, Y., & Arakawa, H. (2004) · Journal of Human Genetics · doi:10.1007/s10038-003-0122-3 · Cited by 234
A ribonucleotide reductase gene is a transcriptional target of p53 and p73
Nakano, K., Bálint, É., Ashcroft, M., & Vousden, K. H. (2000) · Oncogene · doi:10.1038/sj.onc.1203774 · Cited by 233
Glucose Catabolism in Cancer Cells
Mathupala, S. P., Heese, C., & Pedersen, P. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22776 · Cited by 231
Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth
Fei, P., Wang, W., Kim, S.-H., Wang, S., Burns, T. F., Sax, J. K., Buzzai, M., Dicker, D. T., McKenna, W. G., Bernhard, E. J., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.012 · Cited by 231
A Role for p53 in the Adaptation to Glutamine Starvation through the Expression of SLC1A3
Tajan, M., Hock, A. K., Blagih, J., Robertson, N. A., Labuschagne, C. F., Kruiswijk, F., Humpton, T. J., Adams, P. D., & Vousden, K. H. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.005 · Cited by 230
Zhang, P., Tu, B., Wang, H., Cao, Z., Tang, M., Zhang, C., Gu, B., Li, Z., Wang, L., Yang, Y., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411026111 · Cited by 224
p53 Activation in Adipocytes of Obese Mice
Yahagi, N., Shimano, H., Matsuzaka, T., Najima, Y., Sekiya, M., Nakagawa, Y., Ide, T., Tomita, S., Okazaki, H., Tamura, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302364200 · Cited by 220
Control of metabolism by p53 – Cancer and beyond
Labuschagne, C. F., Zani, F., & Vousden, K. H. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.06.001 · Cited by 219
Regulation of Proliferation-Survival Decisions during Tumor Cell Hypoxia
Schmaltz, C., Hardenbergh, P. H., Wells, A., & Fisher, D. E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2845 · Cited by 217
Inhibition of p53 preserves Parkin-mediated mitophagy and pancreatic β-cell function in diabetes
Hoshino, A., Ariyoshi, M., Okawa, Y., Kaimoto, S., Uchihashi, M., Fukai, K., Iwai-Kanai, E., Ikeda, K., Ueyama, T., Ogata, T., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318951111 · Cited by 215
Epigenetic regulation of ferroptosis by H2B monoubiquitination and p53
Wang, Y., Yang, L., Zhang, X., Cui, W., Liu, Y., Sun, Q., He, Q., Zhao, S., Zhang, G., Wang, Y., et al. (2019) · EMBO reports · doi:10.15252/embr.201847563 · Cited by 214
Shen, J., Sheng, X., Chang, Z., Wu, Q., Wang, S., Xuan, Z., Li, D., Wu, Y., Shang, Y., Kong, X., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.042 · Cited by 213
Exploring the molecular interface between hypoxia-inducible factor signalling and mitochondria
Thomas, L. W., & Ashcroft, M. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03039-y · Cited by 213
Yoshida, Y., Izumi, H., Torigoe, T., Ishiguchi, H., Itoh, H., Kang, D., & Kohno, K. (2003) · PubMed · Cited by 210
Liu, G., & Chen, X. (2002) · Oncogene · doi:10.1038/sj.onc.1205862 · Cited by 207
Boidot, R., Végran, F., Meulle, A., Le Breton, A., Dessy, C., Sonveaux, P., Lizard-Nacol, S., & Feron, O. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2474 · Cited by 203
Kim, J., Yu, L., Chen, W., Xu, Y., Wu, M., Todorova, D., Tang, Q., Feng, B., Jiang, L., He, J., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2018.12.012 · Cited by 202
p53 regulation of ammonia metabolism through urea cycle controls polyamine biosynthesis
Li, L., Mao, Y., Zhao, L., Li, L., Wu, J., Zhao, M., Du, W., Yu, L., & Jiang, P. (2019) · Nature · doi:10.1038/s41586-019-0996-7 · Cited by 202
p53 Improves Aerobic Exercise Capacity and Augments Skeletal Muscle Mitochondrial DNA Content
Park, J.-Y., Wang, P.-Y., Matsumoto, T., Sung, H. J., Ma, W., Choi, J. W., Anderson, S. A., Leary, S. C., Balaban, R. S., Kang, J.-G., et al. (2009) · Circulation Research · doi:10.1161/circresaha.109.205310 · Cited by 199
Phosphorylation of HDM2 by Akt
Ashcroft, M., Ludwig, R. L., Woods, D. B., Copeland, T. D., Weber, H. O., MacRae, E. J., & Vousden, K. H. (2002) · Oncogene · doi:10.1038/sj.onc.1205276 · Cited by 197
Regulation of AIF expression by p53
Stambolsky, P., Weisz, L., Shats, I., Klein, Y., Goldfinger, N., Oren, M., & Rotter, V (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401965 · Cited by 194
Derdak, Z., Villegas, K. A., Harb, R., Wu, A. M., Sousa, A., & Wands, J. R. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.042 · Cited by 193
ROS-Mediated p53 Induction of Lpin1 Regulates Fatty Acid Oxidation in Response to Nutritional Stress
Assaily, W., Rubinger, D. A., Wheaton, K., Lin, Y., Ma, W., Xuan, W., Brown-Endres, L., Tsuchihara, K., Mak, T. W., & Benchimol, S. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.038 · Cited by 192
Redox Regulation of p53, Redox Effectors Regulated by p53: A Subtle Balance
Maillet, A., & Pervaiz, S. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4434 · Cited by 186
Mirza, A., Wu, Q., Wang, L., McClanahan, T., Bishop, W. R., Gheyas, F., Ding, W., Hutchins, B., Hockenberry, T., Kirschmeier, P., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206477 · Cited by 183
Telomere Dysfunction Induces Sirtuin Repression that Drives Telomere-Dependent Disease
Amano, H., Chaudhury, A., Rodriguez-Aguayo, C., Lu, L., Akhanov, V., Catic, A., Popov, Y. V., Verdin, E., Johnson, H., Stossi, F., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.03.001 · Cited by 182
Role of p53 in mitochondrial biogenesis and apoptosis in skeletal muscle
Saleem, A., Adhihetty, P. J., & Hood, D. A. (2009) · Physiological Genomics · doi:10.1152/physiolgenomics.90346.2008 · Cited by 182
Gao, W., Shen, Z., Shang, L., & Wang, X. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2011.33 · Cited by 178
Kodama, T., Takehara, T., Hikita, H., Shimizu, S., Shigekawa, M., Tsunematsu, H., Li, W., Miyagi, T., Hosui, A., Tatsumi, T., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44957 · Cited by 171
Webster, N. J. G., Resnik, J. L., Reichart, D. B., Strauss, B. E., Haas, M., & Seely, B. L. (1996) · PubMed · Cited by 171
Alarcon, R. M., Koumenis, C., Geyer, R. K., Maki, C. G., & Giaccia, A. J. (1999) · PubMed · Cited by 170
Saleem, A., & Hood, D. A. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.252791 · Cited by 169
Redox regulation of p53 during hypoxia
Chandel, N. S., Vander Heiden, M. G., Thompson, C. B., & Schumacker, P. T. (2000) · Oncogene · doi:10.1038/sj.onc.1203727 · Cited by 167
Ou, Y., Wang, S.-J., Jiang, L., Zheng, B., & Gu, W. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.616359 · Cited by 166
PGC-1α, a Key Modulator of p53, Promotes Cell Survival upon Metabolic Stress
Sen, N., Satija, Y. K., & Das, S. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.044 · Cited by 166
The Central Sirtuin 1/p53 Pathway Is Essential for the Orexigenic Action of Ghrelin
Velásquez, D. A., Martínez, G., Romero, A., Vázquez, M. J., Boit, K. D., Dopeso-Reyes, I. G., López, M., Vidal, A., Nogueiras, R., & Diéguez, C. (2011) · Diabetes · doi:10.2337/db10-0802 · Cited by 161
Yuan, H., Zhang, X., Huang, X., Lu, Y., Tang, W., Man, Y., Wang, S., Xi, J., & Li, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015726 · Cited by 161
p53 Plays a Role in Mesenchymal Differentiation Programs, in a Cell Fate Dependent Manner
Molchadsky, A., Shats, I., Goldfinger, N., Pevsner-Fischer, M., Olson, M., Rinon, A., Tzahor, E., Lozano, G., Zipori, D., Sarig, R., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003707 · Cited by 161
SKN-1 and Nrf2 couples proline catabolism with lipid metabolism during nutrient deprivation
Pang, S., Lynn, D. A., Lo, J. Y., Paek, J., & Curran, S. P. (2014) · Nature Communications · doi:10.1038/ncomms6048 · Cited by 158
Ferredoxin reductase is critical for p53-dependent tumor suppression via iron regulatory protein 2
Zhang, Y., Qian, Y., Zhang, J., Yan, W., Jung, Y.-S., Chen, M., Huang, E. C., Lloyd, K. C. K., Duan, Y., Wang, J., et al. (2017) · Genes & Development · doi:10.1101/gad.299388.117 · Cited by 156
Andrysík, Z., Galbraith, M. D., Guarnieri, A. L., Zaccara, S., Sullivan, K. D., Pandey, A., MacBeth, M. L., Inga, A., & Espinosa, J. M. (2017) · Genome Research · doi:10.1101/gr.220533.117 · Cited by 156
Oncogene-induced senescence results in marked metabolic and bioenergetic alterations
Quijano, C., Cao, L., Fergusson, M. M., Romero, H., Liu, J., Gutkind, S., Rovira, I. I., Mohney, R. P., Karoly, E. D., & Finkel, T. (2012) · Cell Cycle · doi:10.4161/cc.19800 · Cited by 155
The B55α Subunit of PP2A Drives a p53-Dependent Metabolic Adaptation to Glutamine Deprivation
Reid, M. A., Wang, W.-I., Rosales, K. R., Welliver, M. X., Pan, M., & Kong, M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.02.008 · Cited by 154
Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
Yan, W., Liu, S., Xu, E., Zhang, J., Zhang, Y., Chen, X., & Chen, X. (2013) · Oncogene · doi:10.1038/onc.2012.81 · Cited by 153
Chromatin-Bound MDM2 Regulates Serine Metabolism and Redox Homeostasis Independently of p53
Riscal, R., Schrepfer, E., Arena, G., Cissé, M. Y., Bellvert, F., Heuillet, M., Rambow, F., Bonneil, É., Sabourdy, F., Vincent, C., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.04.033 · Cited by 149
Self-citationThe critical role of catalase in prooxidant and antioxidant function of p53
Kang, M. Y., Kim, H.-B., Piao, C., Lee, K. K., Hyun, J. W., Chang, I.-Y., & You, H. J. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.102 · Cited by 147
Huo, Y., Cai, H., Teplova, I., Bowman-Colin, C., Chen, G., Price, S. M., Barnard, N., Ganesan, S., Karantza, V., White, E., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0011 · Cited by 145
Tornovsky-Babeay, S., Dadon, D., Ziv, O., Tzipilevich, E., Kadosh, T., Schyr-Ben Haroush, R., Hija, A., Stolovich-Rain, M., Furth-Lavi, J., Granot, Z., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.007 · Cited by 141
Nucleotide Biosynthetic Enzyme GMP Synthase Is a TRIM21-Controlled Relay of p53 Stabilization
Reddy, B. A., van der Knaap, J. A., Bot, A. G. M., Mohd-Sarip, A., Dekkers, D. H. W., Timmermans, M. A. M., Martens, J. W. M., Demmers, J., & Verrijzer, C. P. (2014) · Molecular Cell · doi:10.1016/j.molcel.2013.12.017 · Cited by 141
Regulation of Cellular Metabolism and Hypoxia by p53
Humpton, T. J., & Vousden, K. H. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026146 · Cited by 137
Influence of the RNA-Binding Protein HuR in pVHL-Regulated p53 Expression in Renal Carcinoma Cells
Galbán, S., Martindale, J. L., Mazan-Mamczarz, K., de Silanes, I. L., Fan, J., Wang, W., Decker, J., & Gorospe, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7083-7095.2003 · Cited by 136
Requirement of the ATM/p53 Tumor Suppressor Pathway for Glucose Homeostasis
Armata, H. L., Golebiowski, D., Jung, D. Y., Ko, H. J., Kim, J. K., & Sluss, H. K. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00347-10 · Cited by 133
The effects of p53 on whole organism longevity are mediated by autophagy
Tavernarakis, N., Pasparaki, A., Tasdemir, E., Maiuri, M. C., & Kroemer, G. (2008) · Autophagy · doi:10.4161/auto.6730 · Cited by 132
Regulation of lipid metabolism by p53 – fighting two villains with one sword
Goldstein, I., & Rotter, V. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.06.007 · Cited by 131
Down-regulation of Sphingosine Kinase-1 by DNA Damage
Taha, T. A., Osta, W. A., Kozhaya, L., Bielawski, J., Johnson, K. R., Gillanders, W. E., Dbaibo, G. S., Hannun, Y. A., & Obeid, L. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401259200 · Cited by 131
p53 regulates the cardiac transcriptome
Mak, T. W., Hauck, L., Grothe, D., & Billia, F. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621436114 · Cited by 129
Martoriati, A., Doumont, G., Alcalay, M., Bellefroid, E., Pelicci, P. G., & Marine, J. (2004) · Oncogene · doi:10.1038/sj.onc.1208256 · Cited by 128
Tomita, K., Teratani, T., Suzuki, T., Oshikawa, T., Yokoyama, H., Shimamura, K., Nishiyama, K., Mataki, N., Irie, R., Minamino, T., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.05.013 · Cited by 127
p53 Involvement in the Pathogenesis of Fatty Liver Disease
Yahagi, N., Shimano, H., Matsuzaka, T., Sekiya, M., Najima, Y., Okazaki, S., Okazaki, H., Tamura, Y., Iizuka, Y., Inoue, N., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400884200 · Cited by 127
PCAF is an HIF-1α cofactor that regulates p53 transcriptional activity in hypoxia
Xenaki, G., Ontikatze, T., Rajendran, R., Stratford, I. J., Dive, C., Krstic–Demonacos, M., & Demonacos, C. (2008) · Oncogene · doi:10.1038/onc.2008.192 · Cited by 127
Gaulton, K. J., Willer, C. J., Li, Y., Scott, L. J., Conneely, K. N., Jackson, A., Duren, W. L., Chines, P. S., Narisu, N., Bonnycastle, L. L., et al. (2008) · Diabetes · doi:10.2337/db07-1731 · Cited by 126
Emerging Roles of p53 Family Members in Glucose Metabolism
Itahana, Y., & Itahana, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030776 · Cited by 126
p53 regulates glucose metabolism by miR-34a
Kim, H.-R., Roe, J., Lee, J., Cho, E., & Youn, H. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.06.043 · Cited by 124
p53 as a hub in cellular redox regulation and therapeutic target in cancer
Eriksson, S. E., Ceder, S., Bykov, V. J. N., & Wiman, K. G. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz005 · Cited by 123
p53 Functions in Adipose Tissue Metabolism and Homeostasis
Krstić, J., Reinisch, I., Schupp, M., Schulz, T. J., & Prokesch, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092622 · Cited by 122
Inhibition of Endothelial p53 Improves Metabolic Abnormalities Related to Dietary Obesity
Yokoyama, M., Okada, S., Nakagomi, A., Moriya, J., Shimizu, I., Nojima, A., Yoshida, Y., Ichimiya, H., Kamimura, N., Kobayashi, Y., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.046 · Cited by 121
Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression
Farrell, G. C., Larter, C. Z., Hou, J. Y., Zhang, R. H., Yeh, M. M., Williams, J., Dela Peňa, A., Francisco, R., Osvath, S. R., Brooling, J., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05785.x · Cited by 120
Vergoni, B., Cornejo, P.-J., Gilleron, J., Djedaini, M., Ceppo, F., Jacquel, A., Bouget, G., Ginet, C., Gonzalez, T., Maillet, J., et al. (2016) · Diabetes · doi:10.2337/db16-0014 · Cited by 120
Regulation of iron homeostasis by the p53-ISCU pathway
Funauchi, Y., Tanikawa, C., Lo, P. H. Y., Mori, J., Daigo, Y., Takano, A., Miyagi, Y., Okawa, A., Nakamura, Y., & Matsuda, K. (2015) · Scientific Reports · doi:10.1038/srep16497 · Cited by 115
Dhar, S. K., Xu, Y., Chen, Y., & Clair, D. K. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601083200 · Cited by 114
Kitamura, N., Nakamura, Y., Miyamoto, Y., Miyamoto, T., Kabu, K., Yoshida, M., Futamura, M., Ichinose, S., & Arakawa, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016060 · Cited by 112
Lowman, X. H., Hanse, E. A., Yang, Y., Gabra, M. B. I., Tran, T. Q., Li, H., & Kong, M. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.037 · Cited by 112
Itahana, Y., Han, R., Barbier, S., Lei, Z., Rozen, S., & Itahana, K. (2014) · Oncogene · doi:10.1038/onc.2014.119 · Cited by 110
Kong, B., Wang, Q., Fung, E., Xue, K., & Tsang, B. K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.594812 · Cited by 109
Expression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease
Panasiuk, A. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i38.6198 · Cited by 108
Tumor suppressor p53 negatively regulates glycolysis stimulated by hypoxia through its target RRAD
Zhang, C., Liu, J., Wu, R., Liang, Y., 林美华, Liu, J., Chan, C. S., Hu, W., & Feng, Z. (2014) · Oncotarget · doi:10.18632/oncotarget.2137 · Cited by 108
Hepcidin, a key regulator of iron metabolism, is transcriptionally activated by p53
Weizer‐Stern, O., Adamsky, K., Margalit, O., Ashur‐Fabian, O., Givol, D., Amariglio, N., & Rechavi, G. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06638.x · Cited by 108
The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction
Kung, C.-P., Leu, J. I.-J., Basu, S., Khaku, S., Anokye-Danso, F., Liu, Q., George, D. L., Ahima, R. S., & Murphy, M. E. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.037 · Cited by 106
PML is a ROS sensor activating p53 upon oxidative stress
Niwa-Kawakita, M., Ferhi, O., Soilihi, H., Le Bras, M., Lallemand-Breitenbach, V., & de Thé, H. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20160301 · Cited by 104
p53 Regulates Caveolin Gene Transcription, Cell Cholesterol, and Growth by a Novel Mechanism
Bist, A., Fielding, C. J., & Fielding, P. E. (2000) · Biochemistry · doi:10.1021/bi991721h · Cited by 104
C16-ceramide is a natural regulatory ligand of p53 in cellular stress response
Fekry, B., Jeffries, K. A., Esmaeilniakooshkghazi, A., Szulc, Z. M., Knagge, K. J., Kirchner, D. R., Horita, D. A., Krupenko, S. A., & Krupenko, N. I. (2018) · Nature Communications · doi:10.1038/s41467-018-06650-y · Cited by 103
p53, a novel regulator of lipid metabolism pathways
Goldstein, I., Ezra, O., Rivlin, N., Molchadsky, A., Madar, S., Goldfinger, N., & Rotter, V. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.08.022 · Cited by 102
Molchadsky, A., Ezra, O., Amendola, P. G., Krantz, D., Kogan-Sakin, I., Buganim, Y., Rivlin, N., Goldfinger, N., Folgiero, V, Falcioni, R., et al. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.9 · Cited by 102
p53 as a Regulator of Lipid Metabolism in Cancer
Parrales, A., & Iwakuma, T. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122074 · Cited by 100
Genome-Wide Analysis of p53 under Hypoxic Conditions
Hammond, E. M., Mandell, D. J., Salim, A., Krieg, A. J., Johnson, T. M., Shirazi, H., Attardi, L. D., & Giaccia, A. J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.9.3492-3504.2006 · Cited by 99
Franklin, D. A., He, Y. J., Leslie, P. L., Tikunov, A. P., Fenger, N., Macdonald, J. M., & Zhang, Y. (2016) · Scientific Reports · doi:10.1038/srep38067 · Cited by 99
Sanchez-Macedo, N., Feng, J., Faubert, B., Chang, N., Elia, A., Rushing, E. J., Tsuchihara, K., Bungard, D., Berger, S. L., Jones, R. G., et al. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.168 · Cited by 98
p38 Mitogen-activated Protein Kinase Mediates Hypoxic Regulation of Mdm2 and p53 in Neurons
Zhu, Y., Mao, X. O., Sun, Y., Xia, Z., & Greenberg, D. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200042200 · Cited by 97
Wong, T. S., Rajagopalan, S., Townsley, F. M., Freund, S. M. V., Petrovich, M., Loakes, D., & Fersht, A. R. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn974 · Cited by 95
p53-dependent expression of the stress-induced protein (SIP)
Tomasini, R., Samir, A. A., Pébusque, M., Calvo, E. L., Totaro, M. S., Dagorn, J. C., Dusetti, N., & Iovanna, J. (2002) · European Journal of Cell Biology · doi:10.1078/0171-9335-00248 · Cited by 92
NAD+ Modulates p53 DNA Binding Specificity and Function
McLure, K. G., Takagi, M., & Kastan, M. B. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.22.9958-9967.2004 · Cited by 90
Napoli, M., & Flores, E. R. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.384 · Cited by 90
Identification and cloning of EI24, a gene induced by p53 in etoposide-treated cells.
Lehar, S. M., Nacht, M., Jacks, T., Vater, C. A., Chittenden, T., & Guild, B. C. (1996) · PubMed · Cited by 89
p53 Mediates Autophagy and Cell Death by a Mechanism Contingent On Bnip3
Wang, E. Y., Gang, H., Aviv, Y., Dhingra, R., Margulets, V., & Kirshenbaum, L. A. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01028 · Cited by 88
p53-inducible DHRS3 Is an Endoplasmic Reticulum Protein Associated with Lipid Droplet Accumulation
Deisenroth, C., Itahana, Y., Tollini, L. A., Jin, A., & Zhang, Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.254227 · Cited by 86
Identification of NCF2/p67phox as a novel p53 target gene
Italiano, D., Lena, A. M., Melino, G., & Candi, E. (2012) · Cell Cycle · doi:10.4161/cc.22853 · Cited by 83
p53 promotes the expression of gluconeogenesis-related genes and enhances hepatic glucose production
Goldstein, I., Yizhak, K., Madar, S., Goldfinger, N., Ruppin, E., & Rotter, V. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-9 · Cited by 83
P53-dependent upregulation of neutral sphingomyelinase-2: role in doxorubicin-induced growth arrest
Shamseddine, A. A., Clarke, C. J., Carroll, B. L., Airola, M. V., Mohammed, S., Rella, A., Obeid, L. M., & Hannun, Y. A. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.268 · Cited by 83
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells
Ros, S., Flöter, J., Kaymak, I., Da Costa, C., Houddane, A., Dubuis, S., Griffiths, B., Mitter, R., Walz, S., Blake, S., et al. (2017) · Oncogene · doi:10.1038/onc.2016.477 · Cited by 83
Miyamoto, Y., Kitamura, N., Nakamura, Y., Futamura, M., Miyamoto, T., Yoshida, M., Ono, M., Ichinose, S., & Arakawa, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016054 · Cited by 82
Regulation of Metabolic Activity by p53
Flöter, J., Kaymak, I., & Schulze, A. (2017) · Metabolites · doi:10.3390/metabo7020021 · Cited by 81
Defining a role for sphingosine kinase 1 in p53-dependent tumors
Heffernan-Stroud, L. A., Helke, K. L., Jenkins, R. W., Costa, A.-M. D., Hannun, Y. A., & Obeid, L. M. (2011) · Oncogene · doi:10.1038/onc.2011.302 · Cited by 81
Bergeaud, M., Mathieu, L., Guillaume, A., Moll, U. M., Mignotte, B., Floch, N. L., Vayssière, J., & Rincheval, V. (2013) · Cell Cycle · doi:10.4161/cc.25870 · Cited by 81
p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes
Pappas, K., Xu, J., Zairis, S., Resnick‐Silverman, L., Abate, F., Steinbach, N., Ozturk, S., Saal, L. H., Su, T., Cheung, P., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0089 · Cited by 81
Tumor suppressor p53 links ceramide metabolism to DNA damage response through alkaline ceramidase 2
Xu, R., García-Barros, M., Wen, S., Li, F., Lin, C., Hannun, Y. A., Obeid, L. M., & Mao, C. (2017) · Cell Death and Differentiation · doi:10.1038/s41418-017-0018-y · Cited by 81
Liu, Y., He, Y., Jin, A., Tikunov, A. P., Zhou, L., Tollini, L. A., Leslie, P., Kim, T.-H., Li, L. O., Coleman, R. A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315605111 · Cited by 80
Hoeferlin, L. A., Fekry, B., Öğretmen, B., Krupenko, S. A., & Krupenko, N. I. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.461798 · Cited by 79
Jiang, D., LaGory, E. L., Brož, D. K., Bieging-Rolett, K. T., Brady, C. A., Link, N., Abrams, J., Giaccia, A. J., & Attardi, L. D. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.01.043 · Cited by 77
Lee, S.-J., Lim, C., Min, J.-K., Lee, J.-K., Kim, Y. M., Lee, J., Won, M.-H., & Kwon, Y.-G. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402111 · Cited by 76
Cited by
Macrophages in immunoregulation and therapeutics
Chen, S., Saeed, A. F. U. H., Liu, Q., Jiang, Q., Xu, H., Xiao, G. G., Rao, L., & Duo, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01452-1 · Cited by 2,229
Cancer metabolism: looking forward
Martínez-Reyes, I., & Chandel, N. S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00378-6 · Cited by 1,824
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
Butler, L. M., Perone, Y., Dehairs, J., Lupien, L. E., de Laat, V., Talebi, A., Loda, M., Kinlaw, W. B., & Swinnen, J. V. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.013 · Cited by 589
Understanding the complexity of p53 in a new era of tumor suppression
Liu, Y., Su, Z., Tavana, O., & Gu, W. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.04.009 · Cited by 495
p53, cancer and the immune response
Blagih, J., Buck, M. D., & Vousden, K. H. (2020) · Journal of Cell Science · doi:10.1242/jcs.237453 · Cited by 333
Metadata
- Authors
- Lacroix, M., Riscal, R., Arena, G., Linares, L. K., & Le Cam, L.
- Venue
- Molecular Metabolism
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 33
- Pages
- 2-22
- ISSN
- 2212-8778 (ISSN-L)
- OpenAlex
- W2980921743
- Cited by
- 373
- References
- 255
- FWCI
- 14.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.